Skip to main content

Advertisement

SpringerLink
Log in

Cardiovascular risk assessment in type 2 diabetes mellitus

  • Published:
Current Diabetes Reports Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Pyorala K, Laakso M, Uusitupa M: Diabetes and atherosclerosis: an epidemiologic view. Diabetes Metab Rev 1987, 3:463–524.

    Article  PubMed  CAS  Google Scholar 

  2. Meigs JB, Nathan DM, D’Agostino RB Sr, Wilson PW: Fasting and postchallenge glycemia and cardiovascular disease risk: the Framingham Offspring Study. Diabetes Care 2002, 25:1845–1850.

    Article  PubMed  Google Scholar 

  3. Standl E, Balletshofer B, Dahl B, et al.: Predictors of 10-year macrovascular and overall mortality in patients with NIDDM: the Munich General Practitioner Project. Diabetologia 1996, 39:1540–1545.

    Article  PubMed  CAS  Google Scholar 

  4. Stratton IM, Adler AI, Neil HA, et al.: Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000, 321:405–412.

    Article  PubMed  CAS  Google Scholar 

  5. Cockcroft JR, Wilkinson IB, Evans M, et al.: Pulse pressure predicts cardiovascular risk in patients with type 2 diabetes mellitus. Am J Hypertens 2005, 18:1463–1467.

    Article  PubMed  Google Scholar 

  6. Karim R, Buchanan TA, Hodis HN, et al.: The association of smoking and subclinical atherosclerosis in type 2 diabetes: modification by duration of diabetes. Diabet Med 2005, 22:81–87.

    Article  PubMed  CAS  Google Scholar 

  7. Sullivan PW, Morrato EH, Ghushchyan V, et al.: Obesity, inactivity, and the prevalence of diabetes and diabetes-related cardiovascular comorbidities in the U.S., 2000–2002. Diabetes Care 2005, 28:1599–1603.

    Article  PubMed  Google Scholar 

  8. Stevens RJ, Kothari V, Adler AI, Stratton IM: The UKPDS risk engine: a model for the risk of coronary heart disease in type II diabetes (UKPDS 56). Clin Sci (Lond) 2001, 101:671–679.

    Article  CAS  Google Scholar 

  9. Wilson PW, D’Agostino RB, Levy D, et al.: Prediction of coronary heart disease using risk factor categories. Circulation 1998, 97:1837–1847.

    PubMed  CAS  Google Scholar 

  10. Papaioannou GI, Seip RL, Grey NJ, et al.: Brachial artery reactivity in asymptomatic patients with type 2 diabetes mellitus and microalbuminuria (from the Detection of Ischemia in Asymptomatic Diabetics-brachial artery reactivity study). Am J Cardiol 2004, 94:294–299.

    Article  PubMed  Google Scholar 

  11. Dawson A, Jeyaseelan S, Morris AD, Struthers AD: B-type natriuretic peptide as an alternative way of assessing total cardiovascular risk in patients with diabetes mellitus. Am J Cardiol 2005, 96:933–934.

    Article  PubMed  CAS  Google Scholar 

  12. Shai I, Schulze MB, Manson JE, et al.: A prospective study of lipoprotein(a) and risk of coronary heart disease among women with type 2 diabetes. Diabetologia 2005, 48:1469–1476.

    Article  PubMed  CAS  Google Scholar 

  13. Berneis K, Jeanneret C, Muser J, et al.: Low-density lipoprotein size and subclasses are markers of clinically apparent and non-apparent atherosclerosis in type 2 diabetes. Metabolism 2005, 54:227–234.

    Article  PubMed  CAS  Google Scholar 

  14. Jiang R, Schulze MB, Li T, et al.: Non-HDL cholesterol and apolipoprotein B predict cardiovascular disease events among men with type 2 diabetes. Diabetes Care 2004, 27:1991–1997.

    Article  PubMed  CAS  Google Scholar 

  15. Soedamah-Muthu SS, Chang YF, Otvos J, et al.: Lipoprotein subclass measurements by nuclear magnetic resonance spectroscopy improve the prediction of coronary artery disease in Type 1 diabetes. A prospective report from the Pittsburgh Epidemiology of Diabetes Complications Study. Diabetologia 2003, 46:674–682.

    Article  PubMed  CAS  Google Scholar 

  16. Hoogeveen EK, Kostense PJ, Jakobs C, et al.: Hyperhomocysteinemia increases risk of death, especially in type 2 diabetes: 5-year follow-up of the Hoorn Study. Circulation 2000, 101:1506–1511.

    PubMed  CAS  Google Scholar 

  17. Pai JK, Pischon T, Ma J, et al.: Inflammatory markers and the risk of coronary heart disease in men and women. N Engl J Med 2004, 351:2599–2610.

    Article  PubMed  CAS  Google Scholar 

  18. Coppola G, Corrado E, Muratori I, et al.: Increased levels of C-reactive protein and fibrinogen influence the risk of vascular events in patients with NIDDM. Int J Cardiol 2006, 106:16–20.

    Article  PubMed  Google Scholar 

  19. Tong PC, Lee KF, So WY, et al.: White blood cell count is associated with macro- and microvascular complications in Chinese patients with type 2 diabetes. Diabetes Care 2004, 27:216–222.

    Article  PubMed  Google Scholar 

  20. Saito I, Folsom AR, Brancati FL, et al.: Nontraditional risk factors for coronary heart disease incidence among persons with diabetes: the Atherosclerosis Risk in Communities (ARIC) Study. Ann Intern Med 2000, 133:81–91.

    PubMed  CAS  Google Scholar 

  21. Shai I, Schulze MB, Manson JE, et al.: A prospective study of soluble tumor necrosis factor-alpha receptor II (sTNFRII) and risk of coronary heart disease among women with type 2 diabetes. Diabetes Care 2005, 28:1376–1382.

    Article  PubMed  CAS  Google Scholar 

  22. Goodfellow J, Ramsey MW, Luddington LA, et al.: Endothelium and inelastic arteries: an early marker of vascular dysfunction in non-insulin dependent diabetes. BMJ 1996, 312:744–745.

    PubMed  CAS  Google Scholar 

  23. Caballero AE, Arora R, Saouaf R, et al.: Microvascular and macrovascular reactivity is reduced in subjects at risk for type 2 diabetes. Diabetes 1999, 48:1856–1862.

    Article  PubMed  CAS  Google Scholar 

  24. Chan SY, Mancini GB, Kuramoto L, et al.: The prognostic importance of endothelial dysfunction and carotid atheroma burden in patients with coronary artery disease. J Am Coll Cardiol 2003, 42:1037–1043.

    Article  PubMed  CAS  Google Scholar 

  25. Brevetti G, Silvestro A, Schiano V, Chiariello M: Endothelial dysfunction and cardiovascular risk prediction in peripheral arterial disease: additive value of flow-mediated dilation to ankle-brachial pressure index. Circulation 2003, 108:2093–2098.

    Article  PubMed  Google Scholar 

  26. Jadhav UM, Kadam NN: Non-invasive assessment of arterial stiffness by pulse-wave velocity correlates with endothelial dysfunction. Indian Heart J 2005, 57:226–232.

    PubMed  Google Scholar 

  27. Williams B, Lacy PS, Thorn SM, et al.: Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes. CAFÉ Steering and Writing Committee. Circulation 2006, 113:1213–1225.

    Article  PubMed  CAS  Google Scholar 

  28. Anand DV, Lim E, Lahiri A, Bax JJ: The role of noninvasive imaging in the risk stratification of asymptomatic diabetic subjects. Eur Heart J 2006, 27:905–912.

    Article  PubMed  Google Scholar 

  29. Marwick TH, Case C, Sawada S, et al.: Use of stress echocardiography to predict mortality in patients with diabetes and known or suspected coronary artery disease. Diabetes Care 2002, 25:1042–1048.

    Article  PubMed  Google Scholar 

  30. Vanzetto G, Halimi S, Hammoud T, et al.: Prediction of cardiovascular events in clinically selected high-risk NIDDM patients. Prognostic value of exercise stress test and thallium-201 single-photon emission computed tomography. Diabetes Care 1999, 22:19–26.

    Article  PubMed  CAS  Google Scholar 

  31. Shaw LJ, Raggi P, Schisterman E, et al.: Prognostic value of cardiac risk factors and coronary artery calcium screening for all-cause mortality. Radiology 2003, 228:826–833.

    Article  PubMed  Google Scholar 

  32. Qu W, Le TT, Azen SP, et al.: Value of coronary artery calcium scanning by computed tomography for predicting coronary heart disease in diabetic subjects. Diabetes Care 2003, 26:905–910.

    Article  PubMed  Google Scholar 

  33. Elkeles RS, Feher MD, Flather MD, et al.: The association of coronary calcium score and conventional cardiovascular risk factors in type 2 diabetic subjects asymptomatic for coronary eart disease (The PREDICT Study). Diabet Med 2004, 21:1129–1134.

    Article  PubMed  CAS  Google Scholar 

  34. Yan RT, Anderson TJ, Charbonneau F, et al.: Relationship between carotid artery intima-media thickness and brachial artery flow-mediated dilation in middle-aged healthy men. J Am Coll Cardiol 2005, 45:1980–1986.

    Article  PubMed  Google Scholar 

  35. Chambless LE, Heiss G, Folsom AR, et al.: Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987–1993. Am J Epidemiol 1997, 146:483–494.

    PubMed  CAS  Google Scholar 

  36. Yamasaki Y, Kodama M, Nishizawa H, et al.: Carotid intima-media thickness in Japanese type 2 diabetic subjects: predictors of progression and relationship with incident coronary heart disease. Diabetes Care 2000, 23:1310–1315.

    Article  PubMed  CAS  Google Scholar 

  37. Bernard S, Serusclat A, Targe F, et al.: Incremental predictive value of carotid ultrasonography in the assessment of coronary risk in a cohort of asymptomatic type 2 diabetic subjects. Diabetes Care 2005, 28:1158–1162.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Joslin Diabetes Center, Harvard Medical School, One Joslin Place, 02215, Boston, MA, USA

    Edward S. Horton MD

Authors
  1. Ebaa Al-Ozairi MD, MRCP(UK)
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R. Jan-Willem Middelbeek MS
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Edward S. Horton MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Edward S. Horton MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Al-Ozairi, E., Middelbeek, R.JW. & Horton, E.S. Cardiovascular risk assessment in type 2 diabetes mellitus. Curr Diab Rep 6, 333–336 (2006). https://doi.org/10.1007/s11892-006-0001-3

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11892-006-0001-3

Keywords

Search

Navigation